0.70Open0.70Pre Close0 Volume19 Open Interest15.00Strike Price0.00Turnover254.39%IV27.63%PremiumDec 20, 2024Expiry Date0.00Intrinsic Value100Multiplier6DDays to Expiry0.70Extrinsic Value100Contract SizeAmericanOptions Type-0.1646Delta0.0365Gamma28.23Leverage Ratio-0.1276Theta-0.0007Rho-4.65Eff Leverage0.0066Vega
Zumiez Stock Discussion
Zumiez Q3 Net Income USD 1.159 Million Vs. IBES Estimate USD 440 Thousand
Cathie Wood's Ark Invest boosted its holdings in $Coinbase (COIN.US)$ amidst a crypto industry crackdown by the SEC, driving the stock to nearly five-month lows. Data from Cathie's Ark revealed that three of Wood's funds purchased over 400,000 Coinbase shares, with her main $ARK Innovation ETF (ARKK.US)$ acquiring more than 300,000. This occurred as Coinbase's stock pri...
$DocuSign (DOCU.US)$ +16% (fiscal second-quarter earnings and revenue that topped Wall Street estimates and raised its forecast for fiscal-year billings.)
$Zscaler (ZS.US)$ +15% (the internet security platform issued a forecast better than Wall Street estimates.)
$Tesla (TSLA.US)$ +1.3% (The electric vehicle maker is considering building a lithium refinery for EV battery production in Texas this year, according to an applicati...
• $Okta (OKTA.US)$ +15.8% (In reaction to earnings)
• $StoneCo (STNE.US)$ +12.9% (In reaction to earnings)
• $Turning Point Therapeutics (TPTX.US)$ +116.8% (Bristol Myers Squibb (BMY) will acquire Turning Point Therapeutics for $76,00 per share; expected to be accretive to Non-GAAP earnings per share beginningin2025)
• $Amylyx Pharmaceuticals (AMLX.US)$ +24.9% (receives PDUFA date extension for AMX0035; scheduled for September ...
No comment yet